The prevalence of squamous intraepithelial lesion (SIL) and malignancy for squamous cells of undetermined significance ASC-US in a public health service in Colombia, 2004-2005
DOI:
https://doi.org/10.18597/rcog.418Keywords:
atypical glandular cells, squamous intraepithelial lesions, endocervical curettage, colposcopyAbstract
Objectives: determining the prevalence of intraepithelial squamous lesions and the diagnostic validity of endocervical curettage in patients having cytology reporting atypical glandular cells.
Methods: a cross-sectional study was carried out from January 2000 to June 2006 at La Samaritana teaching hospital, this institution being classified as a third-level hospital in Bogotá, Colombia. Selection criteria consisted of complete information being available regarding the patients'cytology concerning having atypical glandular cells, colposcopy and endocervical curettage. SPSS statistical software (version 15) was used for processing the data.
Results: the records of 105 women having had a positive cytology for atypical glandular cells were analysed. Cervical intraepithelial lesion prevalence was 53% in women having atypical glandular cells, 7% of them having high grade intraepithelial squamous lesions and 46.5% low grade lesions. Endocervical curettage revealed that 86.7% were negative for lesions and 13.3% had low grade intraepithelial lesions. 22 samples provided insufficient data. Histopathological exocervical epithelium results proved negative in 46.5% of cases; a similar 46.5% had low grade intraepithelial lesions and 7% high grade lesions. Agreement between exocervical biopsy and endocervical curettage resulted in a 0.07 Kappa score.
Conclusion: there was a high prevalence of intraepithelial cervical lesion, being found in 53% of women having atypical cells. None of these women had positive result for squamocellular carcinoma or adenocarcenoma.
Author Biographies
Sandra Huertas-Pacheco
Jinneth Acosta-Forero
Martha Cabarcas-Santoya
Ángel Yobany Sánchez-Merchán
Orlando Ricaurte-Guerrero
References
Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000: Cancer Incidence, Mortality and prevalence worldwide. Lyon, France: IARC Press, 2001.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
Arrosi S, Sankaranarayanan R, Parkin DM. Incidence and mortality of cervical cancer in Latin America. Salud Publica Mex 2003;45:S306-14.
Lewis MJ. Análisis de la situación del cáncer cervicouterino en América Latina y el Caribe. Washington, D.C.: OPS/OMS; 2004.
Piñeros M, Murillo R. Incidencia de cáncer en Colombia: importancia de las fuentes de información en la obtención de cifras estimativas. Rev Colomb Cancerol 2004;8:5-14.
Läärä E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987;1:1247-9.
Sasieni P, Adams J. Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. BMJ 1999;318:1244-5.
Sackett DL, Strauss SE, Richardson WS, Resenberg W, Haynes RB. Diagnóstico y cribado. En: Medicina basada en la evidencia. Madrid: Hartcourt; 2001. p. 57-81.
Macgregor JE, Campbello MK, Mann EM, Swanson KY. Screening for cervical intraepithelial neoplasia in northeast Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. BMJ 1994;308:1407-11.
Hernández-Avila M, Lazcano-Ponce EC, de Ruiz PA, Romieu I. Evaluation of the cervical cancer screening programme in Mexico: a population-based case-control study. Int J Epidemiol 1998;27:370-6.
Miller AB. Quality assurance in screening strategies. Virus Res 2002;89:295-9.
Kurman R, Solomon D. The Bethesda system for reporting cervical/vaginal cytologic diagnoses: definitions, criteria and explanatory notes for terminology and specimen adequacy. New York: Springer-Verlag; 1994.
Stoler MH, Cervical Cancer Screening in the HPV Era: What Is the Standard of Care? CME/CMLE. Medscape 2005. Visitado 2007 Oct 19. Disponible en: http://www.medscape.com/viewarticle/518860
Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
Stoler MH. Does every little cell count? Don't "ASCUS". Cancer 1999;87:45-7.
Emerson RE, Puzanov A, Brunnemer C, Younger C, Cramer H. Long-term follow-up of women with atypical squamous cells of undetermined significance (ASCUS) Diagn Cytopathol 2002;27:153-7.
Gaitán Duarte H, Rubio Romero JA, Eslava Schmalbach J. Asociación de la citología cérvico-vaginal inflamatoria con la lesión intraepitelial cervical en pacientes de una clínica de salud sexual y reproductiva en Bogotá, Colombia 1999-2003. Rev Salud Pública 2004;6:253-69.
Howell LP, Davis RL. Follow-up of Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance. Diagn Cytopathol 1996;14:20-4.
Ghoussoub RA, Rimm DL. Degree of dysplasia following diagnosis of atypical squamous cells of undetermined significance is influenced by patient history and type of follow-up. Diagn Cytopathol 1997;17:14-9.
Williams ML, Rimm DL, Pedigo MA, Frable WJ. Atypical squamous cells of undetermined significance: correlative histologic and follow-up studies from an academic medical center. Diagn Cytopathol 1997;16:1-7.
Dvorak KA, Finnemore M, Maksem JA. Histology correlation with atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) cytology diagnoses: an argument to ensure ASCUS follow-up that is as aggressive as that for LSIL. Diagn Cytopathol 1999;21:292-5.
Aragón ME, y cols. Células escamosas atípicas de significado indeterminado: Correlación colpohistopatológica. Controversias en Ginecología y Obstetricia 2003;2:4-10.
Abati A, Jaffurs W, Wilder AM. Squamous atypia in the atrophic cervical vaginal smear: a new look at an old problem. Cancer 1998;84:218-25.
Singh V, Parashari A, Satyanarayana L, Sodhani P, Gupta MM, Sehgal A. Biological behavior and etiology of inflammatory cervical smears. Diagn Cytopathol 1999;20:199-202.
González MA. Patología cervical y el reporte de ASCUS en la citología cervical. Rev Colomb Obstet Ginecol 2003;54:193-8.
Flynn K, Rimm DL, Diagnosis of "ASC-US" in women over age 50 is less likely to be associated with dysplasia. Diagn Cytopathol 2001;24:132-6.
Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810-9.
Herbert A, Turnbull LS. Terminology in cervical citology. Current Diagnostic Pathology 2006;12:89-97.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
